Cargando…

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study

BACKGROUND: Cancer patients may receive a high number of medications with the potential to prolong QT interval and subsequent TdP (torsades de pointes). This study aimed to identify the prevalence of QT prolonging drugs, their TdP risk, QT prolonging drug-drug interactions (QT-DDIs), levels, predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Qasim, Ismail, Mohammad, Khan, Sehrash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710059/ https://www.ncbi.nlm.nih.gov/pubmed/29191244 http://dx.doi.org/10.1186/s40360-017-0181-2

Ejemplares similares

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
por: Ismail, Mohammad, et al.
Publicado: (2020)

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021)

Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units
por: Fernandes, Flávia Medeiros, et al.
Publicado: (2019)

Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2020)

An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval
por: Lorberbaum, Tal, et al.
Publicado: (2016)

An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval
por: Yiginer, Omer, et al.
Publicado: (2015)

Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose
por: Soroosh, Davood, et al.
Publicado: (2019)

The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation
por: Wiśniowska, Barbara, et al.
Publicado: (2016)

Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2021)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
por: Rowe, Elizabeth J., et al.
Publicado: (2022)

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy
por: Sala, Michela, et al.
Publicado: (2005)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients
por: Schächtele, Simone, et al.
Publicado: (2016)

Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation
por: Zhang, Juan, et al.
Publicado: (2021)

Multiple drugs: Anaphylactic reaction, progression of prolonged QT interval and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: QT prolongation: case report
Publicado: (2022)

Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Choi, Byung Jin, et al.
Publicado: (2021)

Drug interactions with QT-prolonging antibiotics: an epidemiological study in community pharmacies
por: Vandael, Eline, et al.
Publicado: (2015)

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
por: Ninkovic, Vladan M., et al.
Publicado: (2016)

Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance
por: Vargas, Hugo M, et al.
Publicado: (2015)

Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia
por: Gaviria-Mendoza, Andrés, et al.
Publicado: (2022)

Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19
por: Schiavone, Marco, et al.
Publicado: (2022)

Managing drug-induced QT prolongation in clinical practice
por: Khatib, Rani, et al.
Publicado: (2021)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study
por: Ali, Zahid, et al.
Publicado: (2020)

Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
por: Wiśniowska, Barbara, et al.
Publicado: (2016)

The predictive ability of the QT response in supine-standing test for drug induced QT prolongation
por: Hochstadt, A, et al.
Publicado: (2023)

Impact of Psychotropic Drugs on QT Interval Dispersion in Adult Patients
por: Claudio, Bruno de Queiroz, et al.
Publicado: (2014)

Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
por: Lu, H R, et al.
Publicado: (2008)

Prevalence and risk factors of prolonged corrected QT interval in general Chinese population
por: Ma, Qun, et al.
Publicado: (2019)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2lpb21243ebi92hshc60t9ssfu